David D. Gillespie

797 total citations
21 papers, 651 citations indexed

About

David D. Gillespie is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, David D. Gillespie has authored 21 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in David D. Gillespie's work include Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). David D. Gillespie is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). David D. Gillespie collaborates with scholars based in United States, Israel and Malawi. David D. Gillespie's co-authors include Fridolin Sulser, Harold H. Sandstead, D. Hal Manier, Verne C. Lanier, Robert N. Brady, Larry R. Steranka, Tomas de Paulis, Robert Kessler, Ronald G. Manning and R. Mishra and has published in prestigious journals such as American Journal of Clinical Nutrition, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

David D. Gillespie

21 papers receiving 603 citations

Peers

Countries citing papers authored by David D. Gillespie

Since Specialization

Citations

This map shows the geographic impact of David D. Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Gillespie more than expected).

Fields of papers citing papers by David D. Gillespie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Gillespie. The network helps show where David D. Gillespie may publish in the future.

Co-authorship network of co-authors of David D. Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Gillespie. A scholar is included among the top collaborators of David D. Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Gillespie. David D. Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lack of β adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine1The studies reported in this paper were conducted while Irena Nalepa was a Visiting Scientist from the Institute of Pharmacology of the Polish Academy of Sciences, Krakow, Poland.1 1998 ·European Neuropsychopharmacology ·Irena Nalepa, D. Hal Manier, David D. Gillespie, (unknown), Dennis E. Schmidt, Fridolin Sulser	21
2	Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant 1995 ·Brain Research ·(unknown), Irena Nalepa, Mei Huang, (unknown), Alvin M. Burt, (unknown), David D. Gillespie, Fridolin Sulser	47
3	Ethidium bromide fluorescence of 28S ribosomal RNA can be used to normalize samples in Northern or dot blots when analyzing small drug-induced changes in specific mRNA 1992 ·Journal of Neuroscience Methods ·David M. Duhl, David D. Gillespie, Fridolin Sulser	15
4	Dose-dependent down-regulation of ß-adrenoceptors by isoproterenol in rat C6 glioma cells 1992 ·European Journal of Pharmacology Molecular Pharmacology ·P. R. Bieck, David M. Duhl, (unknown), David D. Gillespie, D. Hal Manier, Fridolin Sulser	5
5	High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors 1991 ·Life Sciences ·Robert Kessler, M. Sib Ansari, (unknown), Tomas de Paulis, Jeffrey A. Clanton, R B Innis, Mohammed S. Al‐Tikriti, Ronald G. Manning, David D. Gillespie	67
6	High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. 1991 ·PubMed ·Robert Kessler, (unknown), Tomas de Paulis, (unknown), J A Clanton, H. E. SMITH, Ronald G. Manning, David D. Gillespie, Michael H. Ebert	76
7	The serotonin/norepinephrine-link in brain. II. Role of serotonin in the regulation of beta adrenoceptors in the low agonist affinity conformation. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·David D. Gillespie, D. Hal Manier, Elaine Sanders‐Bush, Fridolin Sulser	32
8	5,7-Dihydroxytryptamine-induced lesions of serotonergic neurons and desipramine-induced down-regulation of cortical beta adrenoceptors: A re-evaluation 1987 ·Biochemical Pharmacology ·D. Hal Manier, David D. Gillespie, Fridolin Sulser	22
9	Characterizing forest stands with multi-incidence angle and multi-polarized SAR data 1987 ·Advances in Space Research ·R. M. Hoffer, Diego F. Lozano-García, David D. Gillespie	8
10	Analysis of multiple incidence angle SIR-B data for determining forest stand characteristics 1986 ·NASA Technical Reports Server (NASA) ·R. M. Hoffer, Diego F. Lozano-García, David D. Gillespie, (unknown), (unknown)	12
11	Desensitization by Antidepressants of Central Norepinephrine Receptor Systems Coupled to Adenylate Cyclase^a 1984 ·Annals of the New York Academy of Sciences ·Fridolin Sulser, David D. Gillespie, R. Mishra, D. Hal Manier	31
12	PHYSIOLOGICAL MECHANISMS AND SIGNIFICANCE OF CHANGES IN THE REGULATION OF BETA ADRENOCEPTORS BY ANTIDEPRESSANTS 1984 ·Clinical Neuropharmacology ·Fridolin Sulser, David D. Gillespie, D. Hal Manier	3
13	A pivotal role for serotonin (5HT) in the regulation of beta adrenoceptors by antidepressants: reversibility of the action of parachlorophenylalanine by 5-hydroxytroptophan 1984 ·Cellular and Molecular Life Sciences ·D. Hal Manier, David D. Gillespie, Larry R. Steranka, Fridolin Sulser	33
14	Effect of selective monoamine oxidase inhibition by clorgyline and deprenyl on the norepinephrine receptor-coupled adenylate cyclase system in rat cortex 1983 ·Psychopharmacology ·R. Mishra, David D. Gillespie, Moussa B. H. Youdim, Fridolin Sulser	11
15	Oxaprotiline: Induction of central noradrenergic subsensitivity by its (+)-enantiomer 1982 ·Life Sciences ·R. Mishra, David D. Gillespie, Richard Lovell, Ronald D. Robson, Fridolin Sulser	26
16	Development of and recovery from subsensitivity of the noradrenergic cyclic AMP generating system in brain 1980 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·D. Hal Manier, David D. Gillespie, Fridolin Sulser	5
17	Amphetamine normalizes reserpine-induced supersensitivity of the noradrenaline receptor coupled adenylate cyclase system in brain 1980 ·Journal of Pharmacy and Pharmacology ·David D. Gillespie, D. Hal Manier, Fridolin Sulser	2
18	EFFECT OF ANALGESICS AND EXPOSURE TO CIGARETTE SMOKE ON THE METABOLISM OF ACETOPHENETIDIN BY RAT TISSUES 1973 ·Drug Metabolism and Disposition ·Richard M. Welch, (unknown), David D. Gillespie	8
19	Zinc Deficiency: Effect on Brain of the Suckling Rat 1972 ·Pediatric Research ·Harold H. Sandstead, David D. Gillespie, Robert N. Brady	64
20	Zinc and Wound Healing 1970 ·American Journal of Clinical Nutrition ·Harold H. Sandstead, Verne C. Lanier, (unknown), David D. Gillespie	125

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact